Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells

por Momeny, Majid, Sabourinejad, Zahra, Zarrinrad, Ghazaleh, Moghaddaskho, Farima, Eyvani, Haniyeh, Yousefi, Hassan, Mirshahvaladi, Shahab, Poursani, Ensieh M., Barghi, Farinaz, Poursheikhani, Arash, Dardaei, Leila, Bashash, Davood, Ghazi-Khansari, Mahmoud, Tavangar, Seyyed M., Dehpour, Ahmad R., Yaghmaie, Marjan, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Publicado 2017

Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells

por Momeny, Majid, Moghaddaskho, Farima, Gortany, Narges K., Yousefi, Hassan, Sabourinejad, Zahra, Zarrinrad, Ghazaleh, Mirshahvaladi, Shahab, Eyvani, Haniyeh, Barghi, Farinaz, Ahmadinia, Leila, Ghazi-Khansari, Mahmoud, Dehpour, Ahmad R., Amanpour, Saeid, Tavangar, Seyyed M., Dardaei, Leila, Emami, Amir H., Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Publicado 2017

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells

por Momeny, Majid, Zarrinrad, Ghazaleh, Moghaddaskho, Farima, Poursheikhani, Arash, Sankanian, Ghazaleh, Zaghal, Azam, Mirshahvaladi, Shahab, Esmaeili, Fatemeh, Eyvani, Haniyeh, Barghi, Farinaz, Sabourinejad, Zahra, Alishahi, Zivar, Yousefi, Hassan, Ghasemi, Reza, Dardaei, Leila, Bashash, Davood, Chahardouli, Bahram, Dehpour, Ahmad R., Tavakkoly-Bazzaz, Javad, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Publicado 2017